NEW HAVEN, Conn., Dec. 15 Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections announced today it has entered into a ...
NASHVILLE, Tenn. and GLEN ROCK, N.J., Dec. 15 HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. ...
MALVERN, Pa. and WALTHAM, Mass., Dec. 15 Arlington Medical Resources (AMR) and Decision Resources find that methicillin-resistant Staphylococcus aureus (MRSA) is the most concerning pathogen to surveyed European infectious disease ...
TEL AVIV, Israel, December 14 Sigma Pharmaceuticals Ltd. and Neurim Pharmaceuticals Ltd. announce Licensing Agreement for Circadin(R) - prolonged release melatonin for primary insomnia in Australia. Circadin(R), currently approved for use in 33 ...
WALTHAM, Mass., Dec. 14 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the launches of several new agents, the atrial fibrillation drug market ...
FORT COLLINS, Colo., Dec. 14 Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an ...
Caverta is a quite a popular drug which is used to treat problems related to impotency in men and can help improve their sex lives to a great extent. Launched by Ranbaxy it is very much similar to Viagra and contains active ingredients used for ...
ORLANDO, Fla., Dec. 10 In its ever-continuing quest to provide consumers with the most delicious and nutritious beverages on the planet, Drenchers® has improved its all natural 100 percent super juice, Immunity, and Fit 'N Lean Immunity by ...
SAN DIEGO, Dec. 10, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the ...
Nashville, Tenn. , Dec. 9 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has entered into an exclusive agreement with DB Pharm Korea Co. Ltd. , a Korean-based pharmaceutical company, for ...
Zydus Lifesciences, an Indian pharmaceutical company, revealed on Saturday that it has obtained the final approval from the US Food and Drug Administration (USFDA) to distribute a generic drug for arthritis and various other ...
Providing rotavirus vaccine to infants in neonatal intensive care units (NICUs) is safe and does not lead to disease outbreaks ( ). Rotaviruses are majorly responsible for diarrheal disease among infants and young children. The vaccine, which ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
The efficacy of mRNA vaccine technology demonstrated during the COVID-19 pandemic provides optimism for its utilization in mitigating preventable illnesses across various disease domains ( ). ...
An intradermal monkeypox (Mpox) vaccination regimen with reduced dosage proved safe and elicited an antibody response comparable to the standard regimen at six weeks (two weeks post-second dose) ( ). ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers